Comprehensive Psychiatry
Volume 51, Issue 5 , Pages 510-515 , September 2010

Association between Novelty Seeking of opiate-dependent patients and the catechol-O-methyltransferase Val158Met polymorphism

  • Zsolt Demetrovics

      Affiliations

    • Institutional Group on Addiction Research, Eötvös Loránd University, Budapest H-1064, Hungary
    • ,
  • Gabor Varga

      Affiliations

    • Institute of Psychology, Eötvös Loránd University, Budapest H-1064, Hungary
    • ,
  • Anna Szekely

      Affiliations

    • Institute of Psychology, Eötvös Loránd University, Budapest H-1064, Hungary
    • ,
  • Andrea Vereczkei

      Affiliations

    • Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, POB 260, Budapest H-1444, Hungary
    • ,
  • Jozsef Csorba

      Affiliations

    • Nyírő Gyula Hospital Drug Outpatient Center, Budapest H-1135, Hungary
    • ,
  • Hedvig Balazs

      Affiliations

    • Institutional Group on Addiction Research, Eötvös Loránd University, Budapest H-1064, Hungary
    • ,
  • Katalin Hoffman

      Affiliations

    • Institutional Group on Addiction Research, Eötvös Loránd University, Budapest H-1064, Hungary
    • ,
  • Maria Sasvari-Szekely

      Affiliations

    • Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, POB 260, Budapest H-1444, Hungary
    • ,
  • Csaba Barta

      Affiliations

    • Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, POB 260, Budapest H-1444, Hungary
    • Corresponding Author InformationCorresponding author. Fax: +36 1 2662615.

References 

  1. Gillespie NA, Zhu G, Neale MC, Heath AC, Martin NG. Direction of causation modeling between cross-sectional measures of parenting and psychological distress in female twins. Behav Genet. 2003;33:383–396
  2. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet. 1996;12:81–84
  3. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet. 1996;12:78–80
  4. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–1531
  5. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975–990
  6. Ronai Z, Szekely A, Nemoda Z, Lakatos K, Gervai J, Staub M, et al. Association between Novelty Seeking and the -521 C/T polymorphism in the promoter region of the DRD4 gene. Mol Psychiatry. 2001;6:35–38
  7. Szekely A, Ronai Z, Nemoda Z, Kolmann G, Gervai J, Sasvari-Szekely M. Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms. Am J Med Genet B Neuropsychiatr Genet. 2004;126B:106–110
  8. Munafo MR, Yalcin B, Willis-Owen SA, Flint J. Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data. Biol Psychiatry. 2008;63:197–206
  9. Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51:593–628
  10. Mukherjee N, Kidd KK, Pakstis AJ, Speed WC, Li H, Tarnok Z, et al. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase. Mol Psychiatry. 2008;
  11. Hosak L. Role of the COMT gene Val158Met polymorphism in mental disorders: a review. Eur Psychiatry. 2007;22:276–281
  12. Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I, et al. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet. 1999;88:628–633
  13. Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, Lachman HM. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am J Med Genet B Neuropsychiatr Genet. 2003;120B:29–34
  14. Rujescu D, Giegling I, Gietl A, Hartmann AM, Moller HJ. A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biol Psychiatry. 2003;54:34–39
  15. Golimbet VE, Alfimova MV, Gritsenko IK, Ebstein RP. Relationship between dopamine system genes and extraversion and novelty seeking. Neurosci Behav Physiol. 2007;37:601–606
  16. Hosak L, Libiger J, Cizek J, Beranek M, Cermakova E. The COMT Val158Met polymorphism is associated with novelty seeking in Czech methamphetamine abusers: preliminary results. Neuro Endocrinol Lett. 2006;27:799–802
  17. World Health Organization . International Statistical Classification of Diseases and Related Health Problems (Tenth Revision). Geneva: World Health Organization; 1994;
  18. Rózsa S, Kállai J, Osváth A, Bánki MC. Temperamentum és karakter: Cloninger pszichobiológiai modellje. Budapest: Medicina; 2005;
  19. Cloninger C, Przybeck T, Svrakic D, Wetzel R. The Temperament and Character Inventory (TCI): a guide to its development and use. St Louis: Washington University, Center for Psychobiology of Personality; 1994;
  20. Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J, et al. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:1431–1435
  21. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet. 1997;74:439–442
  22. Li T, Chen CK, Hu X, Ball D, Lin SK, Chen W, et al. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet B Neuropsychiatr Genet. 2004;129B:120–124
  23. Horowitz R, Kotler M, Shufman E, Aharoni S, Kremer I, Cohen H, et al. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am J Med Genet. 2000;96:599–603
  24. Oosterhuis BE, LaForge KS, Proudnikov D, Ho A, Nielsen DA, Gianotti R, et al. Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:793–798
  25. Blum K, Chen AL, Chen TJ, Braverman ER, Reinking J, Blum SH, et al. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model. 2008;5:24
  26. Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Kampman KM, et al. Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology. 2008;33:3078–3084
  27. Yacubian J, Sommer T, Schroeder K, Glascher J, Kalisch R, Leuenberger B, et al. Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci U S A. 2007;104:8125–8130
  28. Bardo MT, Donohew RL, Harrington NG. Psychobiology of novelty seeking and drug seeking behavior. Behav Brain Res. 1996;77:23–43
  29. Wills TA, Windle M, Cleary SD. Temperament and novelty seeking in adolescent substance use: convergence of dimensions of temperament with constructs from Cloninger's theory. Journal Pers Soc Psychol. 1998;74:387–406
  30. Wills TA, Sandy JM, Shinar O. Cloninger's constructs related to substance use level and problems in late adolescence: a mediational model based on self-control and coping motives. Exp Clin Psychopharmacol. 1999;7:122–134
  31. Abbate-Daga G, Amianto F, Rogna L, Fassino S. Do anorectic men share personality traits with opiate dependent men? A case-control study. Addict Behav. 2007;32:170–174
  32. Cohen LJ, Gertmenian-King E, Kunik L, Weaver C, London ED, Galynker I. Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates. Acta Psychiatr Scand. 2005;112:149–158
  33. Fassino S, Daga GA, Delsedime N, Rogna L, Boggio S. Quality of life and personality disorders in heroin abusers. Drug Alcohol Depend. 2004;76:73–80
  34. Le Bon O, Basiaux P, Streel E, Tecco J, Hanak C, Hansenne M, et al. Personality profile and drug of choice; a multivariate analysis using Cloninger's TCI on heroin addicts, alcoholics, and a random population group. Drug Alcohol Depend. 2004;73:175–182
  35. Cloninger CRA. Systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987;44:573–588
  36. Gerra G, Zaimovic A, Timpano M, Zambelli U, Begarani M, Marzocchi GF, et al. Neuroendocrine correlates of temperament traits in abstinent opiate addicts. J Subst Abuse. 2000;11:337–354
  37. Tsai SJ, Hong CJ, Yu YW, Chen TJ. Association study of catechol-O-methyltransferase gene and dopamine D4 receptor gene polymorphisms and personality traits in healthy young chinese females. Neuropsychobiology. 2004;50:153–156
  38. Reuter M, Hennig J. Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion. Neuroreport. 2005;16:1135–1138
  39. Hashimoto R, Noguchi H, Hori H, Ohi K, Yasuda Y, Takeda M, et al. A possible association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and the personality trait of harm avoidance in Japanese healthy subjects. Neurosci Lett. 2007;428:17–20
  40. Palmatier MA, Kang AM, Kidd KK. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry. 1999;46:557–567
  41. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF. Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci U S A. 2009;106:617–622
  42. Matsumoto M, Weickert CS, Beltaifa S, Kolachana B, Chen J, Hyde TM, et al. Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology. 2003;28:1521–1530
  43. Doherty MD, Gratton A. Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats. Brain Res. 1996;715:86–97
  44. Jackson ME, Frost AS, Moghaddam B. Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in the nucleus accumbens. J Neurochem. 2001;78:920–923

PII: S0010-440X(09)00140-0

doi: 10.1016/j.comppsych.2009.11.008

Comprehensive Psychiatry
Volume 51, Issue 5 , Pages 510-515 , September 2010

Article Tools

* Image Usage & Resolution